Analyst increased price target and rating for Ligand Pharmaceuticals.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst increased price target and rating for Ligand Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ligand Pharmaceuticals
biopharmaceutical company based out of La Jolla, California
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Royal Bank of Canada lifted its target price for Aurinia Pharmaceuticals Inc. on October 9, 2026.
- Royal Bank of Canada issued a price objective and Benzinga reported a target price reduction for Aardvark Therapeutics, Inc.
- Analyst raised rating and price target for Atlas Energy Solutions on August 3, 2026, involving Raymond James Financial and RBC.
- Financial institutions, including Royal Bank of Canada and Citigroup, raised price objectives and lifted target prices for Crown.
- Analysts, including Morgan Stanley and Keefe, Bruyette & Woods, adjusted price targets and maintained ratings for Selective Insurance Group on July 8, 2026.